Canada's Ontario province says will sue opioid makers
Canada's most populous province of Ontario on Monday announced plans to sue opioid makers to recover health care costs related to the deadly addiction epidemic.
May 27, 2019
0
5
Canada's most populous province of Ontario on Monday announced plans to sue opioid makers to recover health care costs related to the deadly addiction epidemic.
May 27, 2019
0
5
The number of people believed to have been sickened by a contaminated drug rose to 185 Friday, but US health officials said the death toll from the rare meningitis outbreak held steady at 14.
Oct 12, 2012
0
0
Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, who are ...
May 13, 2013
0
0
A new paper co-written by a University of Illinois Urbana-Champaign legal scholar argues that the state of California's proposal to manufacture and distribute insulin at cost could be a game-changer for curbing out-of-control ...
Jan 24, 2023
0
38
Apremilast (trade name: Otezla) has been available since January 2015 for the treatment of moderate to severe plaque psoriasis or active psoriatic arthritis in adult patients in whom certain pretreatments are not sufficiently ...
May 19, 2015
0
11
A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.
May 22, 2015
0
12
Police have detained nine people suspected of trafficking designer drugs after at least 317 Poles fell ill in recent days from taking the psychoactive substances, including dozens who remained hospitalised Wednesday.
Jul 15, 2015
0
11
When consumers get a prescription drug from the pharmacy, they assume that it's been tested and is safe to use. But what if a drug changes in harmful ways as it sits on the shelf or in the body?
Feb 5, 2021
0
9
Collagenase extracted from Clostridium histolyticum (trade name: Xiapex) was approved in the beginning of 2011 for the treatment of people with Dupuytren's contracture. In an early benefit assessment pursuant to the "Act ...
Jul 12, 2012
0
0
For many immunocompromised people, the COVID-19 pandemic has been a living nightmare—and the omicron variant may make life even more unsettling.
Jan 7, 2022
0
27